-
1
Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
Published 2019-11-01Subjects: Get full text
Article -
2
Pharmacokinetics and bioequivalence of the generic and original dabigatran etexilate after a single dose in healthy volunteers
Published 2024-10-01Subjects: “…dabigatran etexilate…”
Get full text
Article -
3
New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
Published 2018-11-01Subjects: Get full text
Article -
4
-
5
DABIGATRAN ETEXILATE IN ELDERL Y PATIENTS WITH ATRIAL FIBRILLATION: WHATS NEW?
Published 2017-12-01Subjects: “…dabigatran etexilate…”
Get full text
Article -
6
A CLINICAL CASE OF LYSIS OF THROMBUS IN THE LEFT ATRIAL APPENDAGE IN A PATIENT WITH ATRIAL FIBRILLATION PREVIOUSLY TREATED WITH WARFARIN
Published 2020-01-01Subjects: Get full text
Article -
7
PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
Published 2015-09-01Subjects: Get full text
Article -
8
-
9
Systemic Thrombolytic Therapy for Ischemic Stroke in the Course of Anticoagulants
Published 2021-11-01Subjects: Get full text
Article -
10
Comparative study of predisposition to thrombosis with administration of known systemic hemostatic agents and fibrin monomer in the experiment
Published 2023-01-01Subjects: Get full text
Article -
11
Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review
Published 2024-12-01Subjects: Get full text
Article -
12
-
13
Pharmacokinetics and Pharmacogenetics of Dabigatran
Published 2021-03-01Subjects: “…dabigatran etexilate…”
Get full text
Article -
14
Elderly patient with atrial fibrillation and coronary risks
Published 2021-07-01Subjects: Get full text
Article -
15
-
16